Traversa Therapeutics
Latest round
- Series B
Last raised
- Apr 2009
Total raised
- $6.5M
Investors
- 3
About Traversa Therapeutics
Founded in 2006, Traversa Therapeutics, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of RNAi Delivery Technologies.
Who invested in Traversa Therapeutics
3 investors across 2 rounds
See all investors in Traversa Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Traversa Therapeutics
Who invested in Traversa Therapeutics?
Traversa Therapeutics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Traversa Therapeutics raised?
Traversa Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Traversa Therapeutics last raise money?
Traversa Therapeutics's most recent round on record is a Series B, in Apr 2009.
What does Traversa Therapeutics do?
Founded in 2006, Traversa Therapeutics, Inc.
Where is Traversa Therapeutics headquartered?
Traversa Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Traversa Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Traversa Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Traversa Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.